jhu dsip Disability Research Day - Part 1 John's Hopkins University | Engineering
Description
For latest data, check ClinicalTrials.gov (NCT# for CagriSema: NCT04982562) or Novo Nordisk pipeline
The absence of receptor downregulation or tolerance development in research suggests sustained effectiveness without the need for dose escalation over time
While a few focus on niche areas, most practice across multiple areasbringing a broader perspective to the clients they serve
Thats not all
